Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2010

01-03-2010 | Original Article

Clinical Significance of Genotypes and Precore/Basal Core Promoter Mutations in HBV Related Chronic Liver Disease Patients in North India

Authors: Sanjeev Sharma, Balkrishan Sharma, Bhupesh Singla, Yogesh Kumar Chawla, Anuradha Chakraborti, Nitin Saini, Ajay Duseja, Ashim Das, Radha Krishan Dhiman

Published in: Digestive Diseases and Sciences | Issue 3/2010

Login to get access

Abstract

Purpose

Data on genotypes, basal core promoter (BCP) and precore mutants of hepatitis B virus and their association with different HBV related liver disease have been studied inadequately and are controversial. Thus, the aim of this study was to determine the incidence of BCP and precore HBV mutants and their relationship with HBV genotype and different stages of HBV related liver disease in North Indian patients.

Methods

A total 273 patients with different stages of HBV related liver diseases were enrolled. Nested polymerase chain reaction (PCR) was used to amplify the BCP/PC regions. RFLP and direct sequencing were performed to validate the mutations identified in these regions. HBV genotyping was accomplished by multiplex PCR.

Results

Genotype D was the predominant genotype found in each of the various HBV related liver diseases. The BCP mutation was found significantly more often in inactive carriers and compensated cirrhosis as compared to the other groups. The BCP mutation was present in 29.1% of patients with genotype D versus 17.1% with genotype A (P = 0.001). The precore mutation was also more frequently observed with genotype D compared with genotype A (36.9 vs. 4.8%, P = 0.0007).

Conclusion

Genotype D is predominant in North Indian patients. The BCP and precore mutations occur in one-third of HBV positive patients in association with the genotype D. We did not find any correlation with severity of liver disease with genotypes and mutations.
Literature
2.
go back to reference John TJ, Abraham P. Hepatitis B in India: A review of disease epidemiology. Indian Pediatr. 2001;38:1318–1322.PubMed John TJ, Abraham P. Hepatitis B in India: A review of disease epidemiology. Indian Pediatr. 2001;38:1318–1322.PubMed
3.
go back to reference Thyagrajan SP, Jayaram S, Mohanvalli B. Prevalence of HBV in the general population of India. In: Sarin SK, Singhal AK, eds. Hepatitis B in India. New Delhi: CBS Publishers; 1996:9. Thyagrajan SP, Jayaram S, Mohanvalli B. Prevalence of HBV in the general population of India. In: Sarin SK, Singhal AK, eds. Hepatitis B in India. New Delhi: CBS Publishers; 1996:9.
4.
go back to reference Locarnini S, Mcmillan J, Bartholomeusz A. The hepatitis B virus and common mutants. Semin Liver Dis. 2003;23:5–20.CrossRefPubMed Locarnini S, Mcmillan J, Bartholomeusz A. The hepatitis B virus and common mutants. Semin Liver Dis. 2003;23:5–20.CrossRefPubMed
5.
go back to reference Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000;31:1037–1044.CrossRefPubMed Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000;31:1037–1044.CrossRefPubMed
6.
go back to reference Petrosillo N, Ippolito G, Solforosi L, Varaldo PE, Clementi M, Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol. 2000;38:2975–2981.PubMed Petrosillo N, Ippolito G, Solforosi L, Varaldo PE, Clementi M, Manzin A. Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol. 2000;38:2975–2981.PubMed
7.
go back to reference Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575–2583.CrossRefPubMed Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575–2583.CrossRefPubMed
8.
go back to reference Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002;17:165–170.CrossRefPubMed Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002;17:165–170.CrossRefPubMed
9.
go back to reference Kumar A, Kumar SI, Pandey R, Naik S, Aggarwal R. Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. Indian J Gastroenterol. 2005;24:19–22.PubMed Kumar A, Kumar SI, Pandey R, Naik S, Aggarwal R. Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. Indian J Gastroenterol. 2005;24:19–22.PubMed
10.
go back to reference Gandhe SS, Chadha MS, Arankalle VA. Hepatitis B virus genotypes and serotypes in western India: Lack of clinical significance. J Med Virol. 2003;69:324–330.CrossRefPubMed Gandhe SS, Chadha MS, Arankalle VA. Hepatitis B virus genotypes and serotypes in western India: Lack of clinical significance. J Med Virol. 2003;69:324–330.CrossRefPubMed
11.
go back to reference Sugauchi F, Orito E, Kato H, et al. Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus. J Med Virol. 2003;69:33–40.CrossRefPubMed Sugauchi F, Orito E, Kato H, et al. Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus. J Med Virol. 2003;69:33–40.CrossRefPubMed
12.
go back to reference Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol. 2003;41:1277–1279.CrossRefPubMed Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol. 2003;41:1277–1279.CrossRefPubMed
13.
go back to reference Sakugawa H, Nakasone H, Nakayoshi T, et al. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan. J Med Virol. 2002;67:484–489.CrossRefPubMed Sakugawa H, Nakasone H, Nakayoshi T, et al. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan. J Med Virol. 2002;67:484–489.CrossRefPubMed
14.
go back to reference Sherlock S, Dooley J. Virus hepatitis. In: Diseases of the Liver and Biliary System. Blackwell Science;1997:265–302. Sherlock S, Dooley J. Virus hepatitis. In: Diseases of the Liver and Biliary System. Blackwell Science;1997:265–302.
15.
go back to reference Trey C, Lipworth L, Chalmers TC, et al. Fulminant hepatic failure. Presumably contribution of halothane. N Eng J Med. 1968;279:798–801.CrossRef Trey C, Lipworth L, Chalmers TC, et al. Fulminant hepatic failure. Presumably contribution of halothane. N Eng J Med. 1968;279:798–801.CrossRef
16.
go back to reference Fujiwara K, Yokosuka O, Ehata T, et al. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci. 1998;43:368–376.CrossRefPubMed Fujiwara K, Yokosuka O, Ehata T, et al. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci. 1998;43:368–376.CrossRefPubMed
17.
go back to reference Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000—summary of a workshop. Gastroenterology. 2001;120:1828–1853.CrossRefPubMed Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000—summary of a workshop. Gastroenterology. 2001;120:1828–1853.CrossRefPubMed
18.
go back to reference Gentilini P, Laffi G, La Villa G, et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol. 1997;92:66–72.PubMed Gentilini P, Laffi G, La Villa G, et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol. 1997;92:66–72.PubMed
19.
go back to reference Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona–2000 EASL conference. European Association for the Study of Liver. J Hepatol. 2001;35:421–430.CrossRefPubMed Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona–2000 EASL conference. European Association for the Study of Liver. J Hepatol. 2001;35:421–430.CrossRefPubMed
20.
go back to reference Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39:362–364.CrossRefPubMed Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol. 2001;39:362–364.CrossRefPubMed
21.
go back to reference Takahashi K, Aoyama K, Ohno N, et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: Clinical significance and an easy method for detection. J Gen Virol. 1995;76:3159–3164.CrossRefPubMed Takahashi K, Aoyama K, Ohno N, et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: Clinical significance and an easy method for detection. J Gen Virol. 1995;76:3159–3164.CrossRefPubMed
22.
go back to reference Vivekanandan P, Abraham P, Sridharan G, et al. Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin Infect Dis. 2004;38:81–86.CrossRef Vivekanandan P, Abraham P, Sridharan G, et al. Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin Infect Dis. 2004;38:81–86.CrossRef
23.
go back to reference Arankalle VA, Murhekar KM, Gandhe SS, et al. Hepatitis B virus: Predominance of genotype D in primitive tribes of the Andaman and Nicobar Islands, India (1989–1999). J Gen Virol. 2003;84:1915–1920.CrossRefPubMed Arankalle VA, Murhekar KM, Gandhe SS, et al. Hepatitis B virus: Predominance of genotype D in primitive tribes of the Andaman and Nicobar Islands, India (1989–1999). J Gen Virol. 2003;84:1915–1920.CrossRefPubMed
24.
go back to reference Chattopadhyay S, Das BC, Hussain Z, Kar P. Hepatitis B virus genotypes in acute and fulminant hepatitis patients from North India using two different molecular genotyping approaches. Hepatol Res. 2006;35:79–82.CrossRefPubMed Chattopadhyay S, Das BC, Hussain Z, Kar P. Hepatitis B virus genotypes in acute and fulminant hepatitis patients from North India using two different molecular genotyping approaches. Hepatol Res. 2006;35:79–82.CrossRefPubMed
25.
go back to reference Guptan RC, Thakur V, Sarin SK, Banerjee K, Khandekar P. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol. 1996;91:1312–1317.PubMed Guptan RC, Thakur V, Sarin SK, Banerjee K, Khandekar P. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol. 1996;91:1312–1317.PubMed
26.
go back to reference Song BC, Cui XJ, Kim UH, Cho YK. Sequential accumulation of the basal core promoter and the precore mutations in the progression if hepatitis B virus related chronic liver disease. Intervirology. 2006;49:266–273. Song BC, Cui XJ, Kim UH, Cho YK. Sequential accumulation of the basal core promoter and the precore mutations in the progression if hepatitis B virus related chronic liver disease. Intervirology. 2006;49:266–273.
27.
go back to reference Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68:8102–8110.PubMed Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68:8102–8110.PubMed
28.
go back to reference Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990;64:1298–1303.PubMed Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990;64:1298–1303.PubMed
29.
go back to reference Chu CJ, Keeffe EB, Han SH, et al. U.S. HBV epidemiology study group. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003;38:619–628.CrossRefPubMed Chu CJ, Keeffe EB, Han SH, et al. U.S. HBV epidemiology study group. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003;38:619–628.CrossRefPubMed
30.
go back to reference Datta S, Biswas A, Chandra PK, et al. Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and precore mutations in eastern India. Intervirology. 2008;51:275–284.CrossRefPubMed Datta S, Biswas A, Chandra PK, et al. Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and precore mutations in eastern India. Intervirology. 2008;51:275–284.CrossRefPubMed
31.
go back to reference Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol. 2006;78:1047–1054.CrossRefPubMed Chauhan R, Kazim SN, Bhattacharjee J, Sakhuja P, Sarin SK. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. J Med Virol. 2006;78:1047–1054.CrossRefPubMed
32.
go back to reference Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol. 1993;67:5402–5410.PubMed Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol. 1993;67:5402–5410.PubMed
33.
go back to reference Honda A, Yokosuka O, Ehata T, Tagawa M, Imazeki F, Saisho H. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status. J Med Virol. 1999;57:337–344.CrossRefPubMed Honda A, Yokosuka O, Ehata T, Tagawa M, Imazeki F, Saisho H. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status. J Med Virol. 1999;57:337–344.CrossRefPubMed
34.
go back to reference Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA. 1994;91:4077–4081.CrossRefPubMed Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA. 1994;91:4077–4081.CrossRefPubMed
35.
go back to reference Junker-Niepmann M, Bartenschlager R, Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 1990;9:3389–3396.PubMed Junker-Niepmann M, Bartenschlager R, Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 1990;9:3389–3396.PubMed
36.
go back to reference Kramvis A, Kew MC. Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepat. 1998;5:357–367.CrossRefPubMed Kramvis A, Kew MC. Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepat. 1998;5:357–367.CrossRefPubMed
37.
go back to reference Tsugeno H, Yamada G, Kinoshita M, Shimomura H, Iwasaki Y, Tsuji T. Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers. Hepatol Res. 2002;23:48–54.CrossRefPubMed Tsugeno H, Yamada G, Kinoshita M, Shimomura H, Iwasaki Y, Tsuji T. Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers. Hepatol Res. 2002;23:48–54.CrossRefPubMed
38.
go back to reference Sterneck M, Gunther S, Santantonio T, et al. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology. 1996;24:300–306.CrossRefPubMed Sterneck M, Gunther S, Santantonio T, et al. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology. 1996;24:300–306.CrossRefPubMed
39.
go back to reference Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29:976–984.CrossRefPubMed Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29:976–984.CrossRefPubMed
40.
go back to reference Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002;83:1267–1280.PubMed Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002;83:1267–1280.PubMed
41.
go back to reference Laskus T, Rakela J, Persing DH. The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology. 1994;200:809–812.CrossRefPubMed Laskus T, Rakela J, Persing DH. The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology. 1994;200:809–812.CrossRefPubMed
42.
go back to reference Niitsuma H, Ishii M, Saito Y, et al. Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers. J Med Virol. 1995;46:397–402.CrossRefPubMed Niitsuma H, Ishii M, Saito Y, et al. Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers. J Med Virol. 1995;46:397–402.CrossRefPubMed
43.
go back to reference Cabrerizo M, Bartolome J, Ruiz-Moreno M, Otero M, Lopez-Alcorocho JM, Carreno V. Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response. Pediatr Res. 1996;39:980–984.CrossRefPubMed Cabrerizo M, Bartolome J, Ruiz-Moreno M, Otero M, Lopez-Alcorocho JM, Carreno V. Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response. Pediatr Res. 1996;39:980–984.CrossRefPubMed
Metadata
Title
Clinical Significance of Genotypes and Precore/Basal Core Promoter Mutations in HBV Related Chronic Liver Disease Patients in North India
Authors
Sanjeev Sharma
Balkrishan Sharma
Bhupesh Singla
Yogesh Kumar Chawla
Anuradha Chakraborti
Nitin Saini
Ajay Duseja
Ashim Das
Radha Krishan Dhiman
Publication date
01-03-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-1083-y

Other articles of this Issue 3/2010

Digestive Diseases and Sciences 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.